Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate
(21)
- Information Technology Services Directorate (2)
- Isotope Science and Enrichment Directorate (6)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
Researcher
- Andrzej Nycz
- Chris Masuo
- Hongbin Sun
- Luke Meyer
- Prashant Jain
- William Carter
- Alex Walters
- Bruce Moyer
- Debjani Pal
- Ian Greenquist
- Ilias Belharouak
- Jeffrey Einkauf
- Jennifer M Pyles
- Joshua Vaughan
- Justin Griswold
- Kuntal De
- Laetitia H Delmau
- Luke Sadergaski
- Mike Zach
- Nate See
- Nithin Panicker
- Padhraic L Mulligan
- Peter Wang
- Pradeep Ramuhalli
- Praveen Cheekatamarla
- Ruhul Amin
- Sandra Davern
- Vishaldeep Sharma
- Vittorio Badalassi

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

The invention presented here addresses key challenges associated with counterfeit refrigerants by ensuring safety, maintaining system performance, supporting environmental compliance, and mitigating health and legal risks.

A novel approach is presented herein to improve time to onset of natural convection stemming from fuel element porosity during a failure mode of a nuclear reactor.

Recent advances in magnetic fusion (tokamak) technology have attracted billions of dollars of investments in startups from venture capitals and corporations to develop devices demonstrating net energy gain in a self-heated burning plasma, such as SPARC (under construction) and

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

Knowing the state of charge of lithium-ion batteries, used to power applications from electric vehicles to medical diagnostic equipment, is critical for long-term battery operation.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.